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Abstract
Background Colonoscopy is currently the gold standard
for detection of colorectal lesions, but may be limited in
anatomically localising lesions. This audit aimed to deter-
mine the accuracy of colonoscopy lesion localisation, any
subsequent changes in surgical management and any
potentially influencing factors.
Methods Patients undergoing colonoscopy prior to elective
curative surgery for colorectal lesion/s were included from
8 registered U.K. sites (2012–2014). Three sets of data
were recorded: patient factors (age, sex, BMI, screener vs.
symptomatic, previous abdominal surgery); colonoscopy
factors (caecal intubation, scope guide used, colonoscopist
accreditation) and imaging modality. Lesion localisation
was standardised with intra-operative location taken as the
gold standard. Changes to surgical management were
recorded.
Results 364 cases were included; majority of lesions were
colonic, solitary, malignant and in symptomatic referrals.
82% patients had their lesion/s correctly located at colo-
noscopy. Pre-operative CT visualised lesion/s in only 73%
of cases with a reduction in screening patients (64 vs. 77%;
p = 0.008). 5.2% incorrectly located cases at colonoscopy
underwent altered surgical management, including con-
version to open. Univariate analysis found colonoscopy
accreditation, scope guide use, incomplete colonoscopy
and previous abdominal surgery significantly influenced
lesion localisation. On multi-variate analysis, caecal intu-
bation and scope guide use remained significant (HR 0.35,
0.20–0.60 95% CI and 0.47; 0.25–0.88, respectively).
Conclusion Lesion localisation at colonoscopy is incorrect
in 18% of cases leading to potentially significant surgical
management alterations. As part of accreditation, colono-
scopists need lesion localisation training and awareness of
when inaccuracies can occur.
Keywords Colonoscopy  Lesion localisation 
Multi-centred audit
Colonoscopy is currently the gold standard for detection of
colorectal lesions and is recommended in the surveillance
of colorectal cancers and higher risk colorectal lesions [1].
Colonoscopy also has another critical role where, in com-
bination with radiological imaging, colonoscopy anatomi-
cally localises lesions, allowing optimal pre-operative
Pilot study has been presented at Association of Surgeons of Great
Britain and Ireland as an oral presentation and published in peer-
reviewed journals [24, 25].
Provisional findings of The ALLaC Study presented at The
Association of Colorectal Surgeons of America, Florida May 2014.
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surgical planning that is beneficial for both surgeon and
patient. Recent work has suggested that the role of accurate
colonoscopic lesion localisation has become increasingly
important in the modern colorectal era for two reasons [2].
First, the establishment of the NHS Bowel Cancer
Screening Programme (NHSBCSP) has led to the detection
of earlier, and subsequently smaller, lesions that may not
be visible on CT imaging [3]. Second, laparoscopic surgery
with its reduced tactility, particularly with smaller lesions,
is increasingly being offered to patients [4].
Previous publications have varied in the reported accu-
racy of colonoscopy with incorrect lesion localisation
documented from 1.7 to 40.3% [5–20]. The majority of
these studies are retrospective and single centre in design,
making conclusions difficult. A recent small prospective
multi-centre audit in the West of Scotland reported incor-
rect lesion localisation at colonoscopy in 19% of cases that
led to an on-table alteration in surgical management in 6%
[2]. Furthermore, the only factor found to be influencing
accurate lesion localisation was incomplete colonoscopy.
This study aimed to perform a large multi-centre audit
across the U.K. to first assess the accuracy of colonoscopic
lesion localisation and any subsequent operative conse-
quences and second to determine potential influencing
factors.
Methods and patients
Pilot data were collected prospectively from October 2011
to April 2012 and then October 2012 to April 2013, in
hospital sites in Greater Glasgow and Clyde and NHS
Ayrshire and Arran. U.K. data collection started September
2013 to October 2014 from a total of 8 centres: Hairmyres
General, East Kilbride, NHS Lanarkshire; Royal Alexandra
Hospital, Paisley, Western Infirmary, Glasgow and Glas-
gow Royal Infirmary, all NHS Greater Glasgow and Clyde;
Crosshouse Hospital, Kilmarnock, NHS Ayrshire and
Arran; Freeman Hospital and Royal Victoria infirmary,
both Newcastle Hospitals NHS Foundation Trust and
Frenchay Hospital, North Bristol NHS Trust.
The ALLaC study (Accurate Lesion Localisation at
Colonoscopy) was registered with Clinical Effectiveness
Unit, Greater Glasgow and Clyde. Each participating site
registered locally as per local policies and procedures.
Any patient undergoing elective curative surgical
resection for a benign or malignant colorectal lesion/s that
had undergone a colonoscopy prior to surgery was inclu-
ded. All patients had undergone colonoscopy either
because of a positive faecal occult blood test through the
NHS Bowel Cancer Screening Programme (‘screener’) or
because they had been referred from primary care with
colorectal symptoms (‘symptomatic’). The local
investigator at each participating centre identified patients
from departmental multi-disciplinary colorectal cancer
meetings and/or departmental operating lists, and the pro-
forma was completed within 24 h of the patient undergoing
surgery (‘‘Appendix’’). Patients who had undergone neo-
adjuvant chemo-radiotherapy as primary treatment or who
underwent palliative surgery were excluded from this
study.
The study proforma recorded patient, colonoscopic and
imaging factors. Patient factors included: age, sex, BMI
(body mass index), type of referral (screener or symp-
tomatic) and previous abdominal surgery. Colonoscopic
factors recorded were: caecal intubation [defined as ‘pas-
sage of the scope beyond the ileocaecal valve into the
caecal pole or terminal ileum (or anastomosis)’ confirmed
on electronic colonoscopy report] [21]; use of endoscopic
scope guide; reasons for incomplete scope; experience/ac-
creditation of the colonoscopist (Joint Advisory Group
Accreditation awarded); tattoo placed and lesion localisa-
tion [22]. Imaging factors documented were: modality of
imaging used and lesion localisation.
Lesion localisation was standardised into nine segments
(caecum, ascending, hepatic flexure, transverse, splenic
flexure, descending, sigmoid, rectum and ‘other’) with true
lesion location defined as the intra-operative surgical
location to allow comparison with colonoscopic and
imaging localisation. Any changes to planned surgical
management as a result of an alteration in lesion localisa-
tion intra-operatively were recorded.
Statistics
All categorical variables were analysed with the Chi-
squared test with 95% confidence intervals reported where
appropriate. SPSS software (v22.0, Chicago, Illinois, USA)
was used, and p values of less than 5% were taken as
significant.
Results
365 forms were submitted for patients that had undergone
colonoscopy followed by surgical resection in the eight
centres across the U.K. On review of the forms, one case
was excluded due to incomplete information in multiple
sections.
Patient factors (Table 1)
The mean age of the study population was 67.5 years
(27–90 range). There were slightly more males (54%), with
75% being at least overweight and 39% recorded as obese.
The majority of lesions found were in the colon, solitary,
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malignant and in patients referred with symptoms. 51% of
the population had undergone previous abdominal surgery.
Colonoscopy factors (Table 2)
The majority of colonoscopists were accredited (60%), but
only 36% used a scope guide. Only 36% tattooed a lesion’s
location. There was no clear pattern to why certain lesions
were tattooed and others not, as the tattooing was per-
formed throughout the nine segments of the colon. Caecal
intubation was reported in 73% of cases, with reasons
reported for failure as: obstructing lesion 68%, poor bowel
preparation leading to lesion not seen 2%, looping sig-
moid/colon preventing advancement 15% and not reported
15%. Except for the obstructing lesions, all incomplete
colonoscopies went on to have further imaging by CT
pneumocolon.
Colonoscopic lesion localisation (Table 3)
Table 3 shows the true anatomical location of the col-
orectal lesions at surgery, with the majority being colonic.
The lesions are distributed throughout the nine segments
but are mainly in the sigmoid (22.3%), rectum (28%) and
right colon (32.7%). There were small non-significant
variations between surgical and colonoscopic localisation
in most of the segments. However, colonoscopy signifi-
cantly underestimated the number of rectal lesions recor-
ded (77 vs. 102) and significantly overestimated the
number of sigmoid lesions (112 vs. 81).
Overall, two hundred and ninety-nine patients had their
lesion/s located within the correct segment at colonoscopy
(82%).
Imaging lesion localisation and factors (Table 4)
All patients underwent a pre-operative CT (either abdo-
men/pelvis or CT colonography). Pre-operative CT visu-
alised a colorectal lesion/s in only 73% of cases (265/361)
with a significant reduction in visualising lesion/s in
screening patients (64% screener vs. 77% in symptomatic;
p = 0.008). Accurate localisation of lesion/s was reported
in 213 cases, leading overall accuracy of CT to be 59%.
Including only the cases where the lesion/s could be seen
on CT, the accuracy increased to 80% (213/265).
Combining CT and colonoscopy localisation correctly
localised the lesion in 87.1% of cases.
Only 21% underwent pre-operative MRI (n = 75)
potentially reflecting the number of rectal lesions located at
colonoscopy (n = 77). Of those cases, a lesion/s was
localised in 65, with 64 cases being accurate. Overall lesion
localisation for MRI was 88% (65/74 as one case locali-
sation missing).
Table 1 Demographics and
description of patients
undergoing colonoscopy and the
lesions found
Total number of patients 364
Age at scope (mean) 67.5 Range 27–90 years
Male/female 198:166 54:46%
BMIa
Mean 28.3 Range 15–48 kg/m2
\20 14 (5%)
20–24.9 55 (20%)
25.0–30 99 (36%)
[30 105 (39%)
Screening: symptomatica 112:250 31:69%
Previous abdominal surgery: yes:noa 181:176 51:49%
No of lesions found 1:[1a 340:23 94:6%
Malignant lesion:benign lesion 318:46 87:13%
Colonic lesion:rectal lesion 262:102 72:28%
a Missing cases: BMI n = 91; Screening versus symptomatic n = 2; previous abdominal surgery n = 7;
number of lesions found n = 1
Table 2 Description of colonoscopic factors
Total number of patients 364
Accreditation yes:noa 217:145 60:40%
Scope guide yes:noa 125:224 36:64%
Tattoo yes:noa 132:228 37:63%
Caecal intubation yes:no 267:97 73:27%
a Missing cases: accreditation n = 2; scope guide n = 15; tattoo
n = 4
Surg Endosc
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Changes to intra-operative management
Of the total number of lesion/s being incorrectly localised
at colonoscopy (n = 65), 19 cases underwent a change in
intra-operative management (5.2% of all cases) (Table 5).
The majority of these changes were a result of a lesion
being incorrectly localised to the segment more proximal
or distal at colonoscopy, with surgical management
adapting accordingly. The majority of these cases were
open procedures (n = 12) with 3 of the 7 laparoscopic
cases being converted to open and 1 laparoscopic case
performing an open rectal dissection, the later due to the
tumour being more distal than thought pre-operatively.
Further difficulties reported during these 19 altered
surgical management cases included impalpable lesions or
inappropriate/absent tattooing. Strategies employed to
overcome these difficulties were: on-table colonoscopy
with or without colorectal lavage; insertion of hand ports to
allow palpation and accurate small lesion localisation;
further port/s insertion to accommodate for alteration in
surgical resection.
Factors influencing accurate lesion localisation
at colonoscopy (Table 6)
Analysis of patient and colonoscopic factors found that
colonoscopy accreditation, use of the scope guide, caecal
intubation and previous abdominal surgery all significantly
influenced accurate lesion localisation. On multi-variate
analysis, both caecal intubation and use of the scope guide
Table 3 Comparison of
segments of lesion localisation
at colonoscopy versus surgery
Anatomical location Colonoscopy Surgery Difference Chi square
n
(%)
n
(%)
n
Total colonic 287
(79)
262
(72)
0.008*
Total rectal 77
(21)
102
(28)
0.045*
Caecum 68
(18.7)
70
(19.2)
2 0.093
Ascending colon 50
(13.7)
49
(13.5)
1 0.132
Hepatic flexure 15
(4.1)
10
(2.7)
5 0.133
Transverse colon 19
(5.2)
23
(6.3)
4 0.191
Splenic flexure 13
(3.6)
18
(4.9)
5 0.227
Descending colon 9
(2.5)
10
(2.7)
1 0.163
Sigmoid colon 112
(30.8)
81
(22.3)
31 0.025*
Rectum 77
(21.1)
102
(28)
25 0.079
Othera (i.e., anastomosis) 1
(0.3)
1
(0.3)
0 n/a
Bold values indicate p\ 0.05
* p\ 0.05 is level of significance
a These are included in this group, but colonoscopy localisation was incorrect
Table 4 Description of imaging factors
Total number of patients 364
CT performed pre-operatively yes:noa 363:1 99.7:0.3%
CT lesion seen yes:nob 265:96 73:27%
CT lesion correctly localised lesion/s yes:no 213:52 80:20%
MRI performed pre-operatively yes:no 75:289 21:79%
MRI lesion seen yes:nob 65:9 88:12%
MRI lesion correctly localised lesion/s yes:no 64:1 98:2%
a CT included n = 2 CT colons, remainder contrast enhanced CT
abdomen/pelvis
b Missing cases: CT lesion seen n = 3; MRI lesion seen n = 1
Surg Endosc
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remained significant (HR 0.35, 0.20–0.60 95% CI and 0.47;
0.25–0.88, respectively).
Discussion
This prospective multi-centred U.K. study has found
colonoscopy to incorrectly localise colorectal lesions in
18% of cases, leading to altered surgical management in
theatre in 5.2% of cases. Combining the locations of
colonoscopy and CT increased correct lesion localisation to
87.1%. However, this study has confirmed that CT imaging
does not visualise lesions in over a quarter of cases, par-
ticularly in the screening population. With earlier and
smaller lesions expected to continue to be detected with
NHSBCSP, the role of colonoscopy in optimal pre-opera-
tive surgical planning is likely to become increasingly
important in the modern era.
Previous publications have reported significant vari-
ability in the accuracy of colonoscopy to localise lesions,
from 59.7 to 98.3% [5–20]. In a previous publication from
this group, Bryce et al. [2] reviewed the literature high-
lighting many of these studies have been retrospective,
small in number, single centre or single endoscopist in
design. With this heterogeneity, several influencing factors
have been proposed to influence lesion localisation:
increasing age; previous abdominal surgery and incomplete
colonoscopy [5, 8, 14]. This is in comparison with this
current work that has encompassed eight U.K. hospital sites
with over fifty different colonoscopists, several of whom
would have been blinded as the data were recorded peri-
operatively, not at the time of the colonoscopy. Further-
more, the larger number of patients in this study allows for
further statistical analysis of influencing factors, with use
of the scope guide, colonoscopic accreditation, caecal
intubation and previous abdominal surgery all shown to be
significant.
The scope guide is regarded by many colonoscopists as
a teaching aid and is not always routinely available. Indeed
the guidelines for JAG accreditation [22] state that as part
of achieving accreditation, use of the scope guide is not
mandatory. Results from this audit suggest that this
approach needs to be changed as routine use of the scope
guide could educate colonoscopists leading to improved
lesion localisation and as a result should be available on all
screening and symptomatic colonoscopy lists.
Experience of the colonoscopist was also significant
with those not JAG accredited having greater inaccuracies
of localising lesions. Currently, only JAG accredited
colonoscopists can perform screening lists independently
and perhaps this criterion should be applied to symptomatic
referrals so that in the event of diagnosis of a lesion
requiring surgical resection optimal localisation can occur
[22]. In addition, it is worth highlighting that to achieve
accreditation, colonoscopists must achieve competence in
four domains: assessment; consent and communication;
Table 5 Changes in planned surgical management due to altered intra-operative lesion localisation
Planned Actual Reason No of
cases
Lap versus
opena
Right hemicolectomy Extended right
hemicolectomy
Lesion in transverse colon rather than ascending colon 4 x2 open, x2
con
Subtotal colectomy Lesion not caecal, but transverse with erosion into middle
colics
1 X1 con
Anterior resection Left hemicolectomy Lesion in descending, not sigmoid 3 X1 lap; x2
open
Full TME Sigmoid to low-rectum 5 X3 open; x1
lap;
x1 lap
assisted
Left hemicolectomy Anterior resection Descending actually distal sigmoid 1 X1 lap
Sigmoid colectomy Left hemicolectomy Descending lesion rather than sigmoid 1 X1 open
Anterior resection Rectal lesion, not sigmoid, full TME required. 2 X2 open
Ileocolic anastomosis Subtotal colectomy Not anastomotic recurrence, but metachronous locally
advanced sigmoid cancer
1 X1 open
Extended right
hemicolectomy
Subtotal colectomy Splenic flexure lesion, not transverse 1 X1 open
a Open means the case was started and completed open; lap means completed laparoscopically; lap assisted means rectal dissection converted to
open; con means converted from lap to open
Surg Endosc
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endoscopic skills and diagnostic and therapeutic ability
[23]. Within these domains, focused training on localisa-
tion could be made mandatory.
Education would be the first step as many, particularly
non-surgeons, may not be aware of the difficulties for both
patient and surgeon that incorrect localisation and/or
inappropriate tattooing can cause. Included in this approach
could be the proposal that all recto-sigmoid lesions
undergo rigid proctoscopy to confirm tumour height as an
incorrectly located rectal tumour that alters abdominal
surgery to pelvic surgery has major implications for the
patient (higher anastomotic leak risk and urinary and sex-
ual dysfunction). These changes could be supported by the
introduction of specific and mandatory questions on the
electronic colonoscopy record about lesion localisation:
tattoo yes/no; tattoo sites (with proximal and distal options
suggested depending on lesion site); rigid proctoscopy
performed yes/no. Currently, it is optional for the colono-
scopist to include these pieces of information which may
partly explain the low number of lesions tattooed in this
study (36%).
Incomplete colonoscopy means that the colonoscopist
has less visual exposure to the landmarks that they are
trained to recognise and the complete colonoscopy allows
two views (insertion and withdrawal) to increase the
probability of correctly localising a lesion. The two main
reasons for incomplete colonoscopy were obstructing
lesions and sigmoid loops and, especially if the scope guide
is not used, one can see why the colonoscopist could
become disorientated in this situation.
Previous abdominal surgery included all types, not just
colorectal resections, and the experienced colonoscopist is
Table 6 Univariate analysis of
potential influencing patient and
colonoscopic factors on
accurate lesion localisation at
colonoscopy
Total patients
N = 364
Colonoscopic lesion localisation
Accurate
N = 299
Inaccurate
N = 65
p value
(95% CI)
Sex
Male 198 167 31 0.231
Female 166 312 34
Age at scope
\65 146 119 27 0.795
[65 218 180 38
Referral
Symptomatic 250 205 45 0.811
Screening 112 93 19
Abdominal surgery
Yes 181 141 40 0.037*
No 176 152 24 (0.69–2.41)
Caecal intubation
Yes 267 233 34 \0.001*
No 97 66 31 (0.20–0.60)
Scope guide used
Yes 125 111 14 0.034*
No 244 179 45 (0.26–0.91)
Tattoo
Yes 132 106 26 0.270
No 228 189 39
BMI
\20 14 10 4 0.409
20–25 55 44 11
25–29.9 99 84 15
[30 105 91 14
Accreditation
Yes 217 186 31 0.038*
No 145 112 33 (0.47–1.60)
Surg Endosc
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aware that previous surgery can make gentle passage of the
scope difficult, particularly in women who have undergone
a hysterectomy. However, colonoscopists and surgeons
must now be aware that in this same group of patients,
localisation can also be difficult. Only a small number of
patients in this audit had undergone a resection of the colon
or rectum, making conclusions about lesion localisation in
this specific population limited; however, one extreme case
is presented in this study where an anastomotic recurrence
was not correctly reported leading to a surgical alteration in
management.
There was only a 5.2% change in on-table management
due to inaccurate lesion localisation at colonoscopy. This
figure would have been higher if not for CT in combination
with colonoscopy, increasing the number of correctly
localised lesions (to 87.1%). These incorrect localisations
mainly occurred at a more proximal or distal segment with
no change in management. However, when a change in
management occurred (29% of inaccurate cases), it was
significant with 3 laparoscopic cases converted to open and
one requiring an unexpected open TME dissection. This
raises the possibility that incorrect lesion localisation could
make laparoscopic surgery vulnerable to on-
table alterations.
From a surgical viewpoint, these results demonstrate key
areas where incorrectly pre-operative localisation can have
significant operative changes: hepatic and transverse colon
(decision to take middle colics and further dissection for an
extended right hemicolectomy); splenic flexure (extended
right hemicolectomy vs. left hemicolectomy); sigmoid
versus rectum (to perform a total mesorectal exci-
sion/covering ileostomy and consideration to taking down
the splenic flexure). It is beyond the remit of this work to
document what the short- and long-term implications for
the patients with altered management were; however, with
the additions of on-table colonoscopy/lavage, further dis-
section and extra ports, it is unsurprising that many pro-
formas made the comment ‘increased operating time’.
Limitations
This is not a consecutive series of patients, so case selec-
tion bias may be present. Identification of the patients was
left to the local investigator who may have included or
excluded patients for various reasons. Excluding the
authors, the majority of the endoscopists were blinded to
this study. The surgeon and radiologist were not blinded to
the result of the lesion localisation at colonoscopy, leading
to verification bias. This limitation, however, reflects the
pragmatic nature of the study and current clinical practice.
Conclusion
Surgical planning pre-operatively is becoming increasingly
reliant on accurate lesion localisation at colonoscopy.
Colonoscopists need to be educated of the key anatomical
areas where inaccuracies occur and have increased vigi-
lance where caecal intubation has been unsuccessful.
Routine clinical use of the scope guide could potentially
increase correct localisation, minimising on-table alter-
ations in surgical management and optimising outcomes
for surgeons and patients.
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Appendix: Study proforma for the ALLaC study
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The ALLaC Study Proforma 
@TheALLaCStudy 
Please note: use the following subdivisions  
when localising lesion/s. 
Colonoscopy details Date:
Colonoscopist JAG positive Yes/No
MEI/ scope guide used Yes/No
Lesion tattooed Yes/No
Complete scope to caecum Yes/No
If not complete details: Poor bowel prep
Obstructing lesion
Patient instability
Other
Lesion/s localisation (use diagram subdivisions):
Number of lesions: ________
Lesion: benign/ malignant/ high grade dysplasia
Radiology details
CT date Lesion seen:   Yes/No Lesion Localisation:
MRI  date (if applicable) Lesion seen:   Yes/No Lesion Localisation:
Surgery details Date:
Planned operation: Lap/open (circle)
Actual Operation: Lap/open/conversion (circle)
Lesion/s localisation (use diagram subdivisions)
Reason for change:
As a result: Additional or change to lap port sites?
Conversion to open
Increase in surgical time (estimate in minutes)
On-table colonoscopy
Other
Patient details
Name of Hospital
Age/dob:
Male/Female (circle)
Screening patient/symptomatic (circle)
BMI
Previous abdo surgery: Yes/No
If yes – name of op/s
Surg Endosc
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